NAVIDEA BIOPHARMACEUTICALS, INC. (15)

Browse by Contract Category

Contracts

Form of Common Stock Purchase Agreement (Filed With SEC on September 2, 2020)
Amended and Restated Equity Commitment Letter, dated August 14, 2020, between Mastiff Group LLC and Navidea Biopharmaceuticals, Inc (Filed With SEC on August 14, 2020)
Employment Agreement, effective July 27, 2020, by and between Navidea Biopharmaceuticals, Inc. and Jed A. Latkin (Filed With SEC on July 31, 2020)
Termination Agreement by and among the Company, SpePharm and Norgine (Filed With SEC on May 12, 2020)
Stock Purchase Agreement and Letter of Investment Intent, by and between the Company and Keystone (Filed With SEC on September 2, 2020)
Stock Purchase Agreement, effective August 9, 2020, by and between Navidea Biopharmaceuticals, Inc. and Jubilant Radiopharma (Filed With SEC on August 12, 2020)
Stock Purchase Agreement and Letter of Investment Intent by and between the Company and the Investor (Filed With SEC on May 12, 2020)
Stock Purchase Agreement, effective February 14, 2020, by and between Navidea Biopharmaceuticals, Inc. and Keystone Capital Partners, LLC (Filed With SEC on March 18, 2020)
Description of Securities (Filed With SEC on March 18, 2020)
Stock Purchase Agreement, effective February 14, 2020, by and between Navidea Biopharmaceuticals, Inc. and John K. Scott (Filed With SEC on March 18, 2020)
Registration Rights Agreement, dated December 6, 2019, among Navidea Biopharmaceuticals, Inc. and the stockholders named therein (Filed With SEC on December 11, 2019)
Stock Purchase Agreement, dated December 6, 2019, among Navidea Biopharmaceuticals, Inc. and the purchasers named therein (Filed With SEC on December 11, 2019)
Underwriting Agreement, dated June 13, 2019, by and between Navidea Biopharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on June 17, 2019)
Form of Underwriter Warrants of Navidea Biopharmaceuticals, Inc (Filed With SEC on June 17, 2019)
Stock Purchase Agreement, dated March 22, 2019, between Navidea Biopharmaceuticals, Inc. and John K. Scott, Jr (Filed With SEC on May 9, 2019)